Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Goodship

Showing results (81-90 of 137) with videos related to

Pageof 14
Sort By:
Molecular Immunology|December 14, 2011
Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUSLuca Ermini, Timothy H J Goodship, Lisa Strain, et al.
Human Molecular Genetics|October 1, 1993
Isolation of a gene expressed during early embryogenesis from the region of 22q11 commonly deleted in DiGeorge syndromeS Halford, D I Wilson, S C Daw, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 8, 2006
Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutationJ M Saland, S H Emre, B L Shneider, et al.
Journal of Medical Genetics|March 24, 2005
The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohortsV Fremeaux-Bacchi, E J Kemp, J A Goodship, et al.
Plos One|April 25, 2013
Determining the population frequency of the CFHR3/CFHR1 deletion at 1q32Lucy V Holmes, Lisa Strain, Scott J Staniforth, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2006
Complement factor H-associated atypical hemolytic uremic syndrome in monozygotic twins: concordant presentation, discordant response to treatmentJean-Claude Davin, Karolien H Olie, René Verlaak, et al.
Molecular Immunology|March 21, 2007
The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulationD Kavanagh, R Burgess, D Spitzer, et al.
Molecular Immunology|August 3, 2006
Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndromeAnna Richards, M Kathryn Liszewski, David Kavanagh, et al.
Immunobiology|June 9, 2016
Chromosomal rearrangement-A rare cause of complement factor I associated atypical haemolytic uraemic syndromePatrick J Gleeson, Valerie Wilson, Thomas E Cox, et al.
Journal of the American Society of Nephrology : JASN|May 27, 2005
Mutations in complement factor I predispose to development of atypical hemolytic uremic syndromeDavid Kavanagh, Elizabeth J Kemp, Elizabeth Mayland, et al.
Pageof 14

Showing results (81-90 of 137) with videos related to

Sort By:
Pageof 14
Molecular Immunology|December 14, 2011
Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUSLuca Ermini, Timothy H J Goodship, Lisa Strain, et al.
Human Molecular Genetics|October 1, 1993
Isolation of a gene expressed during early embryogenesis from the region of 22q11 commonly deleted in DiGeorge syndromeS Halford, D I Wilson, S C Daw, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 8, 2006
Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutationJ M Saland, S H Emre, B L Shneider, et al.
Journal of Medical Genetics|March 24, 2005
The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohortsV Fremeaux-Bacchi, E J Kemp, J A Goodship, et al.
Plos One|April 25, 2013
Determining the population frequency of the CFHR3/CFHR1 deletion at 1q32Lucy V Holmes, Lisa Strain, Scott J Staniforth, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2006
Complement factor H-associated atypical hemolytic uremic syndrome in monozygotic twins: concordant presentation, discordant response to treatmentJean-Claude Davin, Karolien H Olie, René Verlaak, et al.
Molecular Immunology|March 21, 2007
The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulationD Kavanagh, R Burgess, D Spitzer, et al.
Molecular Immunology|August 3, 2006
Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndromeAnna Richards, M Kathryn Liszewski, David Kavanagh, et al.
Immunobiology|June 9, 2016
Chromosomal rearrangement-A rare cause of complement factor I associated atypical haemolytic uraemic syndromePatrick J Gleeson, Valerie Wilson, Thomas E Cox, et al.
Journal of the American Society of Nephrology : JASN|May 27, 2005
Mutations in complement factor I predispose to development of atypical hemolytic uremic syndromeDavid Kavanagh, Elizabeth J Kemp, Elizabeth Mayland, et al.
Pageof 14